Literature DB >> 31050126

Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes.

Regitse H Christensen1,2, Christian S Hansen2, Bernt Johan von Scholten2, Magnus T Jensen3,4, Bente K Pedersen1, Peter Schnohr5, Tina Vilsbøll2,6, Peter Rossing2,6, Peter G Jørgensen4.   

Abstract

The aim of this study was to investigate the association of epicardial (EAT) and pericardial (PAT) adipose tissues with myocardial function in type 2 diabetes (T2D). EAT and PAT were measured by ultrasound in 770 patients with T2D and 234 age- and sex-matched non-diabetic controls. Echocardiography was performed, including tissue Doppler imaging and 2D speckle tracking. Patients with T2D versus controls had increased EAT (4.6 ± 1.8 mm vs. 3.4 ± 1.2 mm, P < 0.0001) and PAT (6.3 ± 2.8 mm vs. 5.3 ± 2.4 mm, P < 0.0001). EAT and PAT were associated with structural cardiac measures both in T2D patients and controls (all P < 0.043), but only in T2D patients with functional measures: PAT was associated with impaired global longitudinal strain [beta coefficient (SE)] [0.11% (0.04), P = 0.002], while EAT was associated with reduced diastolic function by lateral early diastolic myocardial velocity (e'lat ) [-0.31 (0.05) cm/s, P = 0.001], mitral inflow velocities: peak early (E)/peak atrial (A) ratio [-0.02 (0.01), P = 0.001] and lateral E/e'lat [0.36 (0.10), P < 0.001]. However, no interaction was found between diabetes status and PAT (P = 0.75) or EAT (P = 0.45). Adipose tissue in intimate relation to the myocardium is higher in patients with T2D versus controls and is associated with functional myocardial measures in T2D.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac adipose tissue; diastolic dysfunction; epicardial adipose tissue; pericardial adipose tissue; systolic dysfunction; type 2 diabetes

Mesh:

Year:  2019        PMID: 31050126     DOI: 10.1111/dom.13758

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  11 in total

1.  Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy.

Authors:  Gianluca Iacobellis; Sara Basilico; Alexis Elias Malavazos
Journal:  Handb Exp Pharmacol       Date:  2022

Review 2.  Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes.

Authors:  Teresa Salvatore; Raffaele Galiero; Alfredo Caturano; Erica Vetrano; Luca Rinaldi; Francesca Coviello; Anna Di Martino; Gaetana Albanese; Sara Colantuoni; Giulia Medicamento; Raffaele Marfella; Celestino Sardu; Ferdinando Carlo Sasso
Journal:  Biomolecules       Date:  2022-01-21

3.  Pericardial adipose tissue is an independent risk factor of coronary artery disease and is associated with risk factors of coronary artery disease.

Authors:  Yueqiao Si; Zhixin Cui; Jingyi Liu; Zhenjiang Ding; Chao Han; Ruijuan Wang; Tong Liu; Lixian Sun
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

4.  Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.

Authors:  Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2019-08-30       Impact factor: 9.951

5.  Association of pericardial adipose tissue with left ventricular structure and function: a region-specific effect?

Authors:  Chol Shin; Seong Hwan Kim; Jin-Seok Kim; Seon Won Kim; Jong Seok Lee; Seung Ku Lee; Robert Abbott; Ki Yeol Lee; Hong Euy Lim; Ki-Chul Sung; Goo-Yeong Cho; Kwang Kon Koh; Sun H Kim
Journal:  Cardiovasc Diabetol       Date:  2021-01-25       Impact factor: 9.951

Review 6.  The Relationship of Epicardial Adipose Tissue and Cardiovascular Disease in Chronic Kidney Disease and Hemodialysis Patients.

Authors:  Kultigin Turkmen; Hakan Ozer; Mariusz Kusztal
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

7.  Multiparametric CMR imaging of myocardial structure and function changes in diabetic mini-pigs with preserved LV function: a preliminary study.

Authors:  Yukun Cao; Heshui Shi; Guozhu Shao; Yue Cui; Xiaoyu Han; Jia Liu; Yumin Li; Na Li
Journal:  BMC Cardiovasc Disord       Date:  2022-04-02       Impact factor: 2.298

8.  Epicardial Adipose Tissue: The Genetics Behind an Emerging Cardiovascular Risk Marker.

Authors:  João Adriano Sousa; Maria Isabel Mendonça; Marco Serrão; Sofia Borges; Eva Henriques; Sónia Freitas; Margarida Tentem; Marina Santos; Pedro Freitas; António Ferreira; Graça Guerra; António Drumond; Roberto Palma Reis
Journal:  Clin Med Insights Cardiol       Date:  2021-07-03

9.  Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes.

Authors:  Emilie H Zobel; Regitse Højgaard Christensen; Signe A Winther; Philip Hasbak; Christian Stevns Hansen; Bernt J von Scholten; Lene Holmvang; Andreas Kjaer; Peter Rossing; Tine W Hansen
Journal:  Cardiovasc Diabetol       Date:  2020-02-10       Impact factor: 9.951

10.  Predictors of Epicardial Fat Volume Decrease after Dapagliflozin Treatment in Patients with Type 2 Diabetes.

Authors:  Adina Braha; Alin Albai; Bogdan Timar; Daniela Cipu; Lucian Vasiluță; Ovidiu Potre; Romulus Timar
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.